Publication | Closed Access

A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer

Dose EscalationMedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyLung CancerCancer Research